On Nov. 26, the Biden administration announced a plan to require Medicare and Medicaid to cover weight loss medications like ...

Though some doctors have been trying to classify “obesity” as a “chronic illness,” being fat and being ill aren’t the same ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

Since 2018, Ozempic's net price has fallen from $531 to $290, or 45%. Since 2020, Rybelsus' net price has dropped from $376 to $296, or 21%. In contrast, Wegovy's net price has increased 21% since ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The plans from the Department of Health and Human Services come on the heels of criticism Ozempic and other weight loss ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...